PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Meet Insilico in Singapore: Alex Zhavoronkov PhD shares insights into various aspects of AI-powered drug discovery

Meet Insilico in Singapore: Alex Zhavoronkov PhD shares insights into various aspects of AI-powered drug discovery
2024-07-26
(Press-News.org)

From July 30-31, Alex Zhavoronkov, PhD, founder and co-CEO of clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine will be attending SCRI Clinical Trials Symposium 2024 at Raffles City Convention Centre, and Brainstorm AI 2024: The New Race for AI at The Ritz-Carlton, Millenia Singapore, sharing strategic insights with global leaders across the technology and healthcare industries.

On 2:00 p.m, July 31, Alex Zhavoronkov PhD will be speaking at the session named “Methodologies and Considerations for Trials Involving Al-Driven Technologies”, where he is joined by Ms. Karla Childers, the Head of Bioethics-based Science & Technology Policy at Johnson & Johnson, and Associate Professor Tan Cher Heng from Nanyang Technological University (NTU). The session moderated by Associate Professor Liu Nan, Director of Duke-NUS Al+ Medical Sciences Initiative (DAlSl) explores the critical aspects of conducting trials for artificial intelligence (Al) technologies.

Organized by the Singapore Clinical Research Institute (SCRI) with the theme of “The Promise of Clinical Trials: Transforming Tomorrow’s Health”, the grand gathering brings together clinicians, researchers, academics, and industry experts in clinical research from around the world, showcasing the value proposition of clinical trials in Singapore, while providing integrated access to trial information for multiple parties engaged.

On 3:10 p.m, July 30, Alex Zhavoronkov PhD will talk under the title “Will AI make death optional” with Christine Yuan Huang, Founder and CEO of Quantum Life, and Jeremy Kahn from Fortune magazine. Topics including AI advancements in longevity research, AI-accelerated drug discovery, and aging prediction are likely to be discussed.

In 2024, the inaugural gathering of Brainstorm AI in Singapore bring together the top minds across Asia from the Fortune Global 500, Fortune Europe 500 and Fortune 500 lists, investors, policymakers, and academics to explore the profound impacts of AI on business, society, and the global order.

Alex Zhavoronkov, PhD, a Clarivate Highly Cited Researcher, is the founder and CEO of Insilico Medicine, which raised over $300 million in multiple rounds from expert investors and spread its business across four continents under his leadership. Since 2012, he has published over 200 peer-reviewed research papers, and 2 books.

Founded in 2014, Insilico Medicine is a pioneer in using generative AI for drug discovery and development. Insilico first described the concept of using generative AI for the design of novel molecules in a peer-reviewed journal in 2016, which laid the foundation for the commercially available Pharma.AI platform spanning across biology, chemistry and clinical development. Powered by Pharma.AI, Insilico has nominated 18 preclinical candidates in its comprehensive portfolio of over 30 assets since 2021 and has received IND approval for 7 molecules. Recently, the company published a paper in Nature Biotechnology presenting the entire R&D journey of its lead drug pipeline, INS018_055, from AI algorithms to Phase II clinical trials. 

 

About Insilico Medicine

Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. 

www.insilico.com

END


[Attachments] See images for this press release:
Meet Insilico in Singapore: Alex Zhavoronkov PhD shares insights into various aspects of AI-powered drug discovery Meet Insilico in Singapore: Alex Zhavoronkov PhD shares insights into various aspects of AI-powered drug discovery 2

ELSE PRESS RELEASES FROM THIS DATE:

Insilico Medicine introduces Science42: DORA, the intelligent writing assistant for accelerated research

Insilico Medicine introduces Science42: DORA, the intelligent writing assistant for accelerated research
2024-07-26
Writing research papers is critical for disseminating scientific findings, but it does come with efficiency burdens, particularly for early-career researchers and non-native English speakers. A survey published in Nature in 2018 indicated that approximately 37% of respondents reported that they spend more than 20 hours a week on writing and revising scientific papers. Recent progress in Natural Language Processing (NLP) technology, particularly with the rise of Generative Pre-trained Transformers (GPT) and other Large Language Models (LLMs), has equipped researchers with a powerful set of tools for processing extensive amounts of literature ...

A deep dive into polyimides for high-frequency wireless telecommunications

A deep dive into polyimides for high-frequency wireless telecommunications
2024-07-26
As 5G technologies continue to evolve, scientists and engineers are already exploring new ways to turn things up a notch for 6G. One of the biggest challenges to address in both 5G and 6G is the many detrimental effects that operating at extremely high frequencies has on wireless communications. At frequencies nearing the terahertz range, problems such as signal attenuation and interference are more prominent, and maintaining signal integrity becomes much harder. Some of these issues can be greatly mitigated by using insulating materials with exceptional dielectric properties. Glass- and ceramic-based insulating materials ...

Green hydrogen from direct seawater electrolysis- experts warn against hype

Green hydrogen from direct seawater electrolysis- experts warn against hype
2024-07-26
At first glance, the plan sounds compelling: invent and develop future electrolysers capable of producing hydrogen directly from unpurified seawater. But a closer look reveals that such direct seawater electrolysers would require years of high-end research. And what is more: DSE electrolyzers are not even necessary - a simple desalination process is sufficient to prepare seawater for conventional electrolyzers. In a commentary in Joule, international experts compare the costs and benefits of the different approaches and come to a clear recommendation. Fresh water is a limited ...

Thousands of birds and fish threatened by mining for clean energy transition

Thousands of birds and fish threatened by mining for clean energy transition
2024-07-26
New research has found that 4,642 species of vertebrate are threatened by mineral extraction around the world through mining and quarrying, and drilling for oil and gas. Mining activity coincides with the world's most valuable biodiversity hotspots, which contain a hyper-diversity of species and unique habitats found nowhere else on Earth. The biggest risk to species comes from mining for materials fundamental to our transition to clean energy, such as lithium and cobalt – both essential components of solar ...

Medical and educational indebtedness among health care workers

2024-07-26
About The Study: U.S. health care workers are more likely than other workers to carry medical and educational debt, collectively owing more than $150 billion. This study found that medical debt was more prevalent among women, home health and nursing home personnel, uninsured individuals, and those with recent hospitalization. Educational debts disproportionately burdened Black workers and younger workers and those with higher education. Corresponding Author: To contact the corresponding author, Kathryn E.W. Himmelstein, M.D., M.S.Ed., email khimmelstein@mgb.org. To access the embargoed study: Visit our For The Media website at this ...

US state restrictions and excess COVID-19 pandemic deaths

2024-07-26
About The Study: This cross-sectional study indicates that stringent COVID-19 restrictions, as a group, were associated with substantial decreases in pandemic mortality, with behavior changes plausibly serving as an important explanatory mechanism. These findings do not support the views that COVID-19 restrictions were ineffective. However, not all restrictions were equally effective; some, such as school closings, likely provided minimal benefit while imposing substantial cost.  Corresponding Author: To contact the corresponding author, Christopher J. Ruhm, Ph.D., email ruhm@virginia.edu. To access the embargoed study: Visit our For The Media website ...

Posttraumatic stress disorder among adults in communities with mass violence incidents

2024-07-26
About The Study: In this survey study of 5,991 participants, presumptive posttraumatic stress disorder (PTSD) was quite prevalent long after the mass violence incident (MVI) among adults in communities that have experienced an MVI, suggesting that MVIs have persistent and pervasive public health impacts on communities, particularly among those with prior exposure to physical or sexual assault and other potentially traumatic events. Focusing exclusively on direct exposure to MVIs is not sufficient. Incorporating these findings into ...

New understanding of fly behavior has potential application in robotics, public safety

New understanding of fly behavior has potential application in robotics, public safety
2024-07-26
RENO, Nevada — Why do flies buzz around in circles when the air is still? And why does it matter? In a paper published online July 26, 2024 by the scientific journal Current Biology, University of Nevada, Reno Assistant Professor Floris van Breugel and Postdoctoral Researcher S. David Stupski respond to this up-until-now unanswered question. And that answer could hold a key to public safety — specifically, how to better train robotic systems to track chemical leaks. “We don’t currently have robotic systems to track odor or chemical plumes,” van Breugel said. “We don’t know how to efficiently find the ...

Investigating the effect of alemtuzumab in allogeneic hematopoietic cell transplantation in patients with inborn errors of immunity

Investigating the effect of alemtuzumab in allogeneic hematopoietic cell transplantation in patients with inborn errors of immunity
2024-07-26
Researchers from Tokyo Medical and Dental University (TMDU) explore the safety and effectiveness of alemtuzumab in an Asian cohort Tokyo, Japan – Allogeneic hematopoietic cell transplantation (HCT) is a commonly used curative therapy for individuals with inborn errors of immunity (IEI). HCT involves introducing stem cells from a compatible donor with the aim of replacing the affected cells in the recipient’s body. Reduced-toxicity conditioning (RTC) is an approach for reducing drug-related toxicities post HCT in patients with IEIs. Alemtuzumab is a humanized anti-CD52 monoclonal antibody that strongly ...

Determining maximum allowable current of an RBS using a directed graph model and greedy algorithm

Determining maximum allowable current of an RBS using a directed graph model and greedy algorithm
2024-07-26
The central principle of the proposed MAC determination method is to connect the batteries within an RBS in parallel to the maximum possible extent, thereby maximizing the output current. To achieve this universally and automatically, the overall process is divided into the 4 steps shown in Fig. 1. First, a directed graph model is established for the subsequent computations. The nodes in the directed graph correspond to the connection points of components in the actual RBS. The edges in the directed graph correspond to the batteries, switches, and external electrical loads in the actual ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Meet Insilico in Singapore: Alex Zhavoronkov PhD shares insights into various aspects of AI-powered drug discovery